Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability

Intellect Dev Disabil. 2019 Jun;57(3):234-241. doi: 10.1352/1934-9556-57.3.234.

Abstract

Nonelderly disabled Medicare beneficiaries have a higher prevalence of chronic conditions, higher utilization of prescription medications, and increased demand for clinical services when compared to beneficiaries 65 years of age and older who are not disabled. Out-of-pocket costs and medication-related problems are major barriers to medication compliance and achievement of therapeutic goals. A school of pharmacy partnered with a nonprofit organization that provides care to individuals with developmental disabilities. The present study highlights outcomes resulting from (a) providing Medicare Part D plan optimization services to lower prescription drug costs and (b) Medication Therapy Management services to evaluate safe and effective medication use in this beneficiary population. Provided interventions were shown to reduce overall medication costs and identify significant medication-related problems.

MeSH terms

  • Adult
  • Aged
  • Cost Savings
  • Developmental Disabilities / drug therapy
  • Developmental Disabilities / economics*
  • Drug Costs
  • Female
  • Health Expenditures*
  • Humans
  • Insurance Benefits / economics
  • Male
  • Medicare Part D / economics*
  • Medication Therapy Management / economics
  • Middle Aged
  • Pilot Projects
  • Prescription Drugs / economics*
  • United States

Substances

  • Prescription Drugs